***B&H Biotechnology is a Finnish-Chinese trading and consulting company specializing in the pharmaceutical, bio-tech and healthcare products and industries.***
We supply high-quality APIs and Intermediates for Anticoagulants, Antidepressants, Cephalosporin and Cardiovascular Drugs, intermediates of Dapoxetine and Oxiracetam, the series products of Nonionic Contrast Agent and Levofloxacin, and functional food ingredients such as 5′-nucleotides, fructose-1,6-diphosphate salts and their derivatives which are widely used in dairy and food industry.
With the close cooperation with local producers and research institutes, we provide custom manufacturing services to customers to develop and produce the new APIs and Intermediates for their own purpose.
We have more than 20 years experience in international trading business and have customers in more than 30 countries and regions in the world. With highly qualified employees and professional team, we have established broad network and good relationship with customers, local producers, and research institutes.
Besides international trading business, we provide consulting services together with Pendiam Oy, a technology consulting company based in Finland, such as technology transfer, new product development, and industrialization. Together with Pendiam, we help you to acquire or license new technologies, develop new products, and commercialize your innovations. Whether you need the best technologies or most suitable partners from Europe or Asia, we will find it for you.
Our mission is to bridge Asia and the West, Academia and Industry.
- Thorough understanding of science, technology, and business of pharmaceutical, biopharmaceutical, biotech, and healthcare.
- Long experience in international business, industry, and academic research in Asia, EU.
- Long experience in establishing and running joint venture companies in China.
- World wide network of professional experts and organizations.
- Integrity and professional expertise.
- Dedication to highest quality.
"Bridging Asia and the West, Academia and Industry"
